![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2211-7393|2|4|172-181
ISSN: 2211-7385
Source: Pharmaceutical Nanotechnology, Vol.2, Iss.4, 2014-12, pp. : 172-181
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Bioactive Compounds, Vol. 1, Iss. 1, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted Anti-Cancer Therapies for Renal Cancer
By Amato Robert J. Jac Jaroslaw
Drugs, Vol. 66, Iss. 17, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Somatostatin Receptor-Targeted Anti-Cancer Therapy
Current Drug Delivery, Vol. 8, Iss. 1, 2011-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Current Medicinal Chemistry, Vol. 24, Iss. 40, 2018-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Bioactive Compounds, Vol. 3, Iss. 1, 2007-03 ,pp. :